Bolt Biotherapeutics Inc (BOLT)

Nov 19, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.54 By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 19, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.54 - Investing.com

Nov 19, 2024

Nov 16, 2024

HC Wainwright Issues Pessimistic Forecast for BOLT Earnings - Defense World

Nov 16, 2024

Nov 15, 2024

Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Bolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look - TipRanks

Nov 14, 2024

Nov 13, 2024

Bolt Biotherapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024

Nov 12, 2024

Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024

Nov 12, 2024

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024

Nov 09, 2024

Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation - Yahoo Finance

Nov 09, 2024

Nov 07, 2024

BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024

Nov 07, 2024

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting - The Manila Times

Nov 07, 2024

Nov 05, 2024

Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - Marketscreener.com

Nov 05, 2024

Nov 02, 2024

Bolt Biotherapeutics (STU:6LP) Cash Flow from Investing : €52.47 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 02, 2024

Oct 30, 2024

Breast Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart

Oct 30, 2024

Oct 22, 2024

BOLT Stock Surges Over 5% Amidst Biotech Sector's Mixed Performa - GuruFocus.com

Oct 22, 2024

Oct 18, 2024

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances - Citeline

Oct 18, 2024

Oct 16, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Broad Biotech Indu - GuruFocus.com

Oct 16, 2024

Oct 13, 2024

Renaissance Technologies LLC Sells 240,898 Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) - Defense World

Oct 13, 2024

Oct 13, 2024

Renaissance Technologies LLC Has $208,000 Stock Holdings in Hesai Group (NASDAQ:HSAI) - Defense World

Oct 13, 2024

Oct 12, 2024

Short Interest in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Drops By 39.1% - Defense World

Oct 12, 2024

Oct 11, 2024

Just Auto Excellence Awards 2024: TomTom - just-auto.com

Oct 11, 2024

Oct 07, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Vol - GuruFocus.com

Oct 07, 2024

Sep 28, 2024

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 14.2% in September - Defense World

Sep 28, 2024

Sep 24, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.61 By Investing.com - Investing.com Canada

Sep 24, 2024

Sep 24, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.61 - Investing.com

Sep 24, 2024

Sep 19, 2024

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Significant Decrease in Short Interest - Defense World

Sep 19, 2024

Sep 07, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.65 By Investing.com - Investing.com Australia

Sep 07, 2024

Sep 06, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.65 - Investing.com

Sep 06, 2024

Sep 05, 2024

Bolt Biotherapeutics Announces Changes to its Board of Directors - ForexTV.com

Sep 05, 2024

Sep 04, 2024

Bolt Biotherapeutics reshuffles board, appoints new chair By Investing.com - Investing.com Canada

Sep 04, 2024

Sep 04, 2024

Bolt Biotherapeutics reshuffles board, appoints new director - Investing.com

Sep 04, 2024

Sep 04, 2024

Bolt Biotherapeutics Announces Board Reshuffle and New Appointment - TipRanks

Sep 04, 2024

Sep 03, 2024

Deadline on Sept. 3rd coming up in Lawsuit for Investors in shares of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) - openPR

Sep 03, 2024

Sep 03, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesBOLT - PR Newswire

Sep 03, 2024

Sep 03, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Sep 03, 2024

Sep 02, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the - EIN News

Sep 02, 2024

Sep 02, 2024

BOLT Investors Have the Opportunity to Lead Bolt - GlobeNewswire

Sep 02, 2024

Sep 02, 2024

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Sep 02, 2024

Sep 02, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.

Sep 02, 2024

Sep 01, 2024

BOLT DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire

Sep 01, 2024

Aug 31, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - The Malaysian Reserve

Aug 31, 2024

Aug 31, 2024

BOLT Deadline: BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

Aug 31, 2024

Aug 30, 2024

BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Aug 30, 2024

Aug 30, 2024

BOLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Aug 30, 2024

Aug 30, 2024

Finansavisen - Finansavisen

Aug 30, 2024